MetaOptics reported a FY2025 net loss attributable to equity holders of SGD 5.4 million, compared with a 179% wider loss in FY2024, as administrative expenses rose to SGD 3.7 million (+311.0%) and R&D expenses increased to SGD 1.9 million (+79.0%). FY2025 revenue was SGD 787,388 (+891.0%), with cost of sales of SGD 627,562, while other income rose to SGD 317,686, including SGD 313,394 of government grants and SGD 4,292 of interest income. Basic and diluted loss per share was 2.54 Singapore cents in FY2025. On the balance sheet, cash at bank was SGD 8.8 million at Dec. 31, 2025, while total assets were SGD 13.6 million and net assets were SGD 10.0 million. Contract liabilities (advances received from customers for equipment sales) increased to SGD 852,892, with the company stating revenue will be recognized within 12 months. The group said it received a SGD 300,000 listing grant from the Monetary Authority of Singapore under the GEMS scheme in connection with its September 2025 IPO on SGX-ST’s Catalist Board, and noted it began presenting expenses by function in FY2025 and adopted IFRS in FY2025 with no material impact from the transition.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metaoptics Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: UL7NYOYURZAEIRCJ) on February 27, 2026, and is solely responsible for the information contained therein.